Status of PD-1 and PD-L1 expression in invasive urothelial carcinoma of the bladder with mismatch repair protein deficiency

It has been reported that mismatch repair deficient (d-MMR) tumors show sensitivity to immune checkpoint inhibitors. We aimed to evaluate the correlation of d-MMR and PD-1/PD-L1 expression in invasive urothelial carcinoma of the bladder. Tissue microarray (TMA) tissues were stained PD-1/PD-L1 and MM...

Full description

Bibliographic Details
Main Authors: Nuran Sungu, Merve M. Kıran
Format: Article
Language:English
Published: Termedia Publishing House 2023-10-01
Series:Polish Journal of Pathology
Subjects:
Online Access:https://www.termedia.pl/Status-of-PD-1-and-PD-L1-expression-in-invasive-urothelial-carcinoma-of-the-bladder-with-mismatch-repair-protein-deficiency,55,51678,1,1.html
_version_ 1797450131384041472
author Nuran Sungu
Merve M. Kıran
author_facet Nuran Sungu
Merve M. Kıran
author_sort Nuran Sungu
collection DOAJ
description It has been reported that mismatch repair deficient (d-MMR) tumors show sensitivity to immune checkpoint inhibitors. We aimed to evaluate the correlation of d-MMR and PD-1/PD-L1 expression in invasive urothelial carcinoma of the bladder. Tissue microarray (TMA) tissues were stained PD-1/PD-L1 and MMR proteins. The expression ratio of these markers has been compared with histopathologic parameters. d-MMR tumors were more superficial muscle invasive (p = 0.012). When the d-MMR, and PD-1/PD-L1 expression ratios were examined, a significant correlation was obtained between the d-MMR and PD-L1 expression ratio of > 5% in both the tumor and immune cells (p = 0.02 and p = 0.004, respectively). The expression ratio was higher in the patients without MMR loss. PD-1 and PD-L1expression in those with MSH6 loss was one or none. When PD1/PDL1 expression was compared with histopathological parameters, a significant relationship was observed between tumor grade and depth of muscle invasion. PD-L1 expression was not observed in the superficial muscle invasive tumors. This study was shown the status of d-MMR and PD-1/PD-L1 in invasive urothelial cancers and their correlation with prognostic markers. PD-1/PD-L1 expression may contribute to the progression and poor prognosis of bladder cancer. However, further studies are required to research the clinical utility.
first_indexed 2024-03-09T14:35:09Z
format Article
id doaj.art-e69e408ff63640558aa045757ee1dc08
institution Directory Open Access Journal
issn 1233-9687
2084-9869
language English
last_indexed 2024-03-09T14:35:09Z
publishDate 2023-10-01
publisher Termedia Publishing House
record_format Article
series Polish Journal of Pathology
spelling doaj.art-e69e408ff63640558aa045757ee1dc082023-11-27T12:45:32ZengTermedia Publishing HousePolish Journal of Pathology1233-96872084-98692023-10-0174316117010.5114/pjp.2023.13222151678Status of PD-1 and PD-L1 expression in invasive urothelial carcinoma of the bladder with mismatch repair protein deficiencyNuran SunguMerve M. KıranIt has been reported that mismatch repair deficient (d-MMR) tumors show sensitivity to immune checkpoint inhibitors. We aimed to evaluate the correlation of d-MMR and PD-1/PD-L1 expression in invasive urothelial carcinoma of the bladder. Tissue microarray (TMA) tissues were stained PD-1/PD-L1 and MMR proteins. The expression ratio of these markers has been compared with histopathologic parameters. d-MMR tumors were more superficial muscle invasive (p = 0.012). When the d-MMR, and PD-1/PD-L1 expression ratios were examined, a significant correlation was obtained between the d-MMR and PD-L1 expression ratio of > 5% in both the tumor and immune cells (p = 0.02 and p = 0.004, respectively). The expression ratio was higher in the patients without MMR loss. PD-1 and PD-L1expression in those with MSH6 loss was one or none. When PD1/PDL1 expression was compared with histopathological parameters, a significant relationship was observed between tumor grade and depth of muscle invasion. PD-L1 expression was not observed in the superficial muscle invasive tumors. This study was shown the status of d-MMR and PD-1/PD-L1 in invasive urothelial cancers and their correlation with prognostic markers. PD-1/PD-L1 expression may contribute to the progression and poor prognosis of bladder cancer. However, further studies are required to research the clinical utility.https://www.termedia.pl/Status-of-PD-1-and-PD-L1-expression-in-invasive-urothelial-carcinoma-of-the-bladder-with-mismatch-repair-protein-deficiency,55,51678,1,1.htmlbladder urothelial cancer pd-1 pd-l1 msi.
spellingShingle Nuran Sungu
Merve M. Kıran
Status of PD-1 and PD-L1 expression in invasive urothelial carcinoma of the bladder with mismatch repair protein deficiency
Polish Journal of Pathology
bladder
urothelial cancer
pd-1
pd-l1
msi.
title Status of PD-1 and PD-L1 expression in invasive urothelial carcinoma of the bladder with mismatch repair protein deficiency
title_full Status of PD-1 and PD-L1 expression in invasive urothelial carcinoma of the bladder with mismatch repair protein deficiency
title_fullStr Status of PD-1 and PD-L1 expression in invasive urothelial carcinoma of the bladder with mismatch repair protein deficiency
title_full_unstemmed Status of PD-1 and PD-L1 expression in invasive urothelial carcinoma of the bladder with mismatch repair protein deficiency
title_short Status of PD-1 and PD-L1 expression in invasive urothelial carcinoma of the bladder with mismatch repair protein deficiency
title_sort status of pd 1 and pd l1 expression in invasive urothelial carcinoma of the bladder with mismatch repair protein deficiency
topic bladder
urothelial cancer
pd-1
pd-l1
msi.
url https://www.termedia.pl/Status-of-PD-1-and-PD-L1-expression-in-invasive-urothelial-carcinoma-of-the-bladder-with-mismatch-repair-protein-deficiency,55,51678,1,1.html
work_keys_str_mv AT nuransungu statusofpd1andpdl1expressionininvasiveurothelialcarcinomaofthebladderwithmismatchrepairproteindeficiency
AT mervemkıran statusofpd1andpdl1expressionininvasiveurothelialcarcinomaofthebladderwithmismatchrepairproteindeficiency